Legend Biotech (LEGN) Tops Q4 EPS by 9c

Legend Biotech (NASDAQ: LEGN) reported Q4 EPS of ($0.16), $0.09 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $186.52 million versus the consensus estimate of $173.99 million.

For earnings history and earnings-related data on Legend Biotech (LEGN) click here.

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• Strategy (MSTR) call put ratio 1.2 calls to 1 put as share price below $100
• Truist: 'We remain bullish on AdaptHealth (AHCO) post management meetings'